Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
86.50
+3.02 (3.62%)
Feb 6, 2026, 4:00 PM EST - Market closed
Ionis Pharmaceuticals Market Cap
Ionis Pharmaceuticals has a market cap or net worth of $14.01 billion as of February 9, 2026. Its market cap has increased by 157.50% in one year.
Market Cap
14.01B
Enterprise Value
13.83B
1-Year Change
157.50%
Ranking
Category
Stock Price
$86.50
Market Cap Chart
Since December 1, 1998, Ionis Pharmaceuticals's market cap has increased from $302.10M to $14.01B, an increase of 4,537.80%. That is a compound annual growth rate of 15.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 14.01B | 9.34% |
| Dec 31, 2025 | 12.81B | 132.13% |
| Dec 31, 2024 | 5.52B | -23.95% |
| Dec 29, 2023 | 7.26B | 35.28% |
| Dec 30, 2022 | 5.37B | 24.86% |
| Dec 31, 2021 | 4.30B | -45.65% |
| Dec 31, 2020 | 7.91B | -6.97% |
| Dec 31, 2019 | 8.50B | 14.26% |
| Dec 31, 2018 | 7.44B | 18.48% |
| Dec 29, 2017 | 6.28B | 8.28% |
| Dec 30, 2016 | 5.80B | -22.07% |
| Dec 31, 2015 | 7.44B | 1.99% |
| Dec 31, 2014 | 7.29B | 57.73% |
| Dec 31, 2013 | 4.62B | 337.67% |
| Dec 31, 2012 | 1.06B | 46.95% |
| Dec 30, 2011 | 719.00M | -28.40% |
| Dec 31, 2010 | 1.00B | -8.12% |
| Dec 31, 2009 | 1.09B | -20.54% |
| Dec 31, 2008 | 1.38B | 0.44% |
| Dec 31, 2007 | 1.37B | 62.24% |
| Dec 29, 2006 | 844.10M | 123.13% |
| Dec 30, 2005 | 378.30M | 11.96% |
| Dec 31, 2004 | 337.90M | -6.42% |
| Dec 31, 2003 | 361.10M | -0.61% |
| Dec 31, 2002 | 363.30M | -65.23% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Revolution Medicines | 18.89B |
| Roivant Sciences | 17.22B |
| Moderna | 15.58B |
| BridgeBio Pharma | 13.27B |
| Ascendis Pharma | 13.11B |
| Exelixis | 11.80B |
| Summit Therapeutics | 11.21B |
| BioMarin Pharmaceutical | 11.11B |